Figure 4: a. Probability of survival in patients selected for treatment with myeloablative conditioning (MAC) or reduced intensity conditioning (RIC) (p = 0.08). Fiveyear survival was 67% in the MAC group and 48% in the RIC group. Multivariate analysis (RH 1.39, p = 0.36). b. Probability of leukemia-free survival (LFS) in patients with acute myeloid leukemia (AML) selected for myeloablative conditioning (MAC) or reduced intensity conditioning (RIC) (p = 0.017). Six-year LFS was 60% in the MAC group and 37% in the RIC group. Multivariate analysis (RH 1.61, p = 0.14). c. Probability of leukemia-free survival in patients with acute myeloid leukemia (AML) selected for myeloablative conditioning (MAC) or reduced intensity conditioning (RIC) with intermediate-risk cytogenetics (p = 0.07). Five-year survival was 61% in the MAC group and 44% in the RIC group.